Comparison of Artemis 2 and Artemis 5 Model Outcomes Using the Impact Probabilistic Risk Assessment Tool BACKGROUND
The Artemis campaign is a Moon exploration program with a series of six planned missions, five of which will be crewed. These five crewed missions will contain a single mission segment (space flight), or multiple mission segments involving space flight (Orion), lunar landing (LTV) and/or space habitat (Gateway). Each crewed segment faces the risk of unique medical conditions, necessitating medical sets/kits tailored to those specificities. To support and enable a data-driven and evidence-based decision-making process through out a mission’s life cycle, a software tool called IMPACT was developed.
Using probabilistic risk assessment (PRA) methodologies, IMPACT (Informing Mission Planning via Analysis of Complex Tradespaces) is a novel tool built for analyzing the possibility of encountering complex medical risks during space flight, and for identifying the medical resources and capabilities needed to treat those potential at-risk medical conditions.
This presentation will seek to compare IMPACT’s computational results upon potential complex space medical conditions (e.g., sprain/strain back or sleep disturbance) using IMPACT’s risk metrics and the associated optimized medical sets/kits between two Artemis missions: single segment Artemis 2 and multi-segmented Artemis 5.
OVERVIEW
By identifying potential medical conditions in space using input criteria such as crew quantity and composition, certain crew physical characteristics, mission duration and mission activities, IMPACT can produce analyses on the type of medical resources and capabilities needed to produce an optimized medical set/kit to address those medical conditions. IMPACT achieves this by performing hundreds of thousands of Monte Carlo simulations of missions to build aggregate pictures of medical risk. IMPACT’s risk metrics include loss of crew life (LOCL) – a measure of crew mortality due to medical conditions in space, return to definitive care (RTDC) – the need to perform crew evacuation, and task time lost (TTL) – a measure of the inability to perform activities due to crew disability. These risk metrics are applied to every medical condition identified by IMPACT’s computation analyses for every segment of the mission. Medical sets/kits are optimized to address these medical conditions but must fit within the stated Artemis Design Reference Mission (DRM) request for mass and volume physical size constraints.
ANTICIPATED ANALYSIS AND CONCLUSION
Using two Artemis missions, Artemis 2 and Artemis 5, IMPACT will provide the analyses for comparison of medical set/kit contents based upon mass and/or volume requirements and identify the at-risk medical conditions within both missions. This paper serves as an initial exploration of probabilistic risk assessment (PRA) medical risk calculations between two crewed Artemis missions and is not intended to be deemed the official medical response for the Artemis campaign.
Document ID
20240012109
Acquisition Source
Johnson Space Center
Document Type
Abstract
Authors
Maribeth Carpenter (Johnson Space Center Houston, United States)
Deb Goodenow (Glenn Research Center Cleveland, United States)
Jim Fenbert (Langley Research Center Hampton, United States)
Courtney Maher (Langley Research Center Hampton, United States)
Qi Lin (Ames Research Center Mountain View, United States)
Aaron Sells (Glenn Research Center Cleveland, United States)
Date Acquired
September 20, 2024
Subject Category
Aerospace Medicine
Meeting Information
Meeting: Human Research Program Investigators’ Workshop (HRP IWS)
Location: Galveston, TX
Country: US
Start Date: January 28, 2025
End Date: January 31, 2025
Sponsors: National Aeronautics and Space Administration
probabilistic risk assessmentIMPACT (Informing Mission Planning via Analysis of Complex Tradespaces)loss of crew life (LOCL)return to definitive care (RTDC)task time lost (TTL)Artemis 2Artemis 5